Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • zee
    NGS specialist
    • Apr 2008
    • 249

    #46
    The latest V2.05 is available to download for not-for-profit and research use. There are no restrictions if you would like to use it in your research work.

    Added features e.g. BS-alignemnt, multithreading, etc are available in the 'Pro'/commercial version.

    Originally posted by seq_GA View Post
    Hi Colin,

    I am wondering whether novocraft 2.04 version is free to download for reaserch purpose?

    Thanks

    Comment

    • sparks
      Senior Member
      • Mar 2008
      • 126

      #47
      Novoalign is still available free for use in non-profit organizations but some of the new features are disabled. The free version will do DNA, miRNA, RNA alignment of single end and paired end reads.
      The commercial versions adds multi-threading, bi-seq alignment, base quality calibration and buying a license also helps fund further development.

      Colin

      Comment

      • BAJ
        Member
        • Nov 2008
        • 15

        #48
        sequence identifiers like >chrY_random

        retracting comment. I have to check some more on my side first.
        Sorry,
        Bernd
        Last edited by BAJ; 08-26-2009, 04:41 AM. Reason: see comment

        Comment

        • sparks
          Senior Member
          • Mar 2008
          • 126

          #49
          It's OK. Some copies of Human Genome have some additional sequence files like:

          chr7_random.fa
          >chr7_random
          gatcatgctattgcactccagcctgggcgacagagtgaaactccatctca
          gaaaaaataaataaaTGAGAGGATCAGCCAACGCATCAGCAAATGTCAGC
          CGGACGGTTTAATTTCCACTCATCCCACGACACGAGGCAACCCTCAAACA
          CACAGGTCCTGGCCATGAAGCCTTCAGGGAATCACAGGACTGGGTGCTGA
          CCCAGAAAACTCTACAAAGCTTTGTGACCAAAGAGGTTCGAGTCCCAAGT
          CCCCTTCAGGAAGAGCTGCAGTCTGCTCATGtgtctaagtttgcctctgt
          tgcttataacaacataccggaaactgggtaaattataaaggaaaggcatt
          tatttctcacagttatgaggctggataaatccagggtcgagtggccacaa
          tggctttcttgctggaggggacttttcagggttcccaggtggcacaggcc

          Some of these must have been included in your index build.
          Colin

          Comment

          Latest Articles

          Collapse

          • SEQadmin2
            Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
            by SEQadmin2


            Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

            The systematic characterization of the human proteome has
            ...
            07-20-2026, 11:48 AM
          • SEQadmin2
            Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
            by SEQadmin2



            Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
            ...
            07-09-2026, 11:10 AM
          • SEQadmin2
            Cancer Drug Resistance: The Lingering Barrier to Rising Survival
            by SEQadmin2



            Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

            There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
            07-08-2026, 05:17 AM

          ad_right_rmr

          Collapse

          News

          Collapse

          Topics Statistics Last Post
          Started by SEQadmin2, 07-20-2026, 11:10 AM
          0 responses
          16 views
          0 reactions
          Last Post SEQadmin2  
          Started by SEQadmin2, 07-13-2026, 10:26 AM
          0 responses
          32 views
          0 reactions
          Last Post SEQadmin2  
          Started by SEQadmin2, 07-09-2026, 10:04 AM
          0 responses
          43 views
          0 reactions
          Last Post SEQadmin2  
          Started by SEQadmin2, 07-08-2026, 10:08 AM
          0 responses
          29 views
          0 reactions
          Last Post SEQadmin2  
          Working...